HC: Skip to main content

Go to the home page

Loading...

Search

Company
Innovation
Pipeline
- Pipeline
- Clinical Development
- Regulatory status
- O-12-M1
- HORIZON
- OCEAN
- ANCHOR
- BRIDGE
- PORT
- LIGHTHOUSE
- Early Access Program
Investors
Sustainability
Media
Career
Contact
- Contact
- Global Headquarters
Oncopeptides Germany

Change Region
Change Language
- English
- Swedish
Loading...
Search

Change Region

Global
United States

You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you to the website of our US operations, Oncopeptides Inc. at www.oncopeptides-us.com
Germany

You are now leaving the global website of Oncopeptides AB, Sweden. The link you clicked will take you to the website of our German operations at www.oncopeptides.de

Change Language

English
Swedish

Investors
Financial reports

Financial reports

Report

Presentation

Webcast

February 16, 2023

Oncopeptides publishes year-end report 2022

Report

Presentation

Webcast

Links

Our history
Pipeline

Press releases
Investor Presentations
The share

Company in brief
Culture & values

Contact
Global Headquarters

About cookies
Privacy Policy
Privacy Policy - Pharmacovigilance
Terms of use
Glossary

© 2023 Oncopeptides AB (publ). All rights reserved. Registration number: 556596-6438